Pfizer
Steven Cureau has extensive experience in operational excellence and vendor management within the pharmaceutical industry, particularly at Pfizer, where Steven has held various leadership roles since 2003. Currently, Steven serves as Director of Enterprise Services Excellence, Performance Management, and Supplier Governance, overseeing the deployment of performance standards across 45 global vendors and improving operational metrics for $300 million in category spend. Steven's previous positions include Director of Global Meetings and Senior Global Category Strategy Manager, where responsibilities encompassed managing large-scale projects, contract development, and compliance. With an MBA in Risk Management and Business Continuity and a BS in Organizational Management, Steven has a strong educational background supporting a robust career in strategy and analytics.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.